EP3004329
AÐFERÐIR TIL AÐ FRAMKALLA FRUMUDAUÐA AÐ HLUTA TIL MEÐ ÞVÍ AÐ NOTA KASPASA FJÖLPEPTÍÐI
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
4.6.2014EP published:
4.3.2020EP application number:
14807405.7
EP translation filed:
15.5.2020Grant published:
15.6.2020EPO information:
European Patent Register
Max expiry date:
3.6.2034Expiry date:
3.6.2025
Title:
METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES
Timeline
Today
4.6.2014EP application
4.3.2020EP Publication
15.5.2020Translation submitted
15.6.2020Registration published
3.6.2025Expires
Owner
Name:
Bellicum Pharmaceuticals, Inc.Address:
2130 West Holcombe Boulevard Ste. 850, Houston, TX 77030, US
Inventor
Name:
SLAWIN, KevinAddress:
Houston, TX 77030, US
Name:
SPENCER, DavidAddress:
Houston, TX 77025, US
Name:
FOSTER, Aaron, EdwardAddress:
Houston, TX 77030, US
Agent
Name:
O3C Konsult ABAddress:
Pajalagatan 56, SE
Priority
Number:
201361831428 PDate:
5.6.2013Country:
US
Number:
201461949847 PDate:
7.3.2014Country:
US
Classification
Categories:
A61K 48/00, A61K 38/16, A61K 38/17, A61K 38/48, A61K 35/17, A61K 35/28, A61K 35/30, A61K 35/545, C12N 5/00, C12N 9/64
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 5.5.2020
Expires: 3.6.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 11.5.2021
Expires: 3.6.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 6.5.2022
Expires: 3.6.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 24.5.2023
Expires: 3.6.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 7.5.2024
Expires: 3.6.2025
Payer: Árnason Faktor ehf.